drugset / Trial / NCT06180031

Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block

NCT06180031

Phase 2/3 Unknown 62 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Our aim will be to compare the analgesic efficacy and safety of magnesium sulphate as an adjuvant to bupivacaine in pericapsular nerve group block in Hip joint surgeries. * Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative. * Our secondary outcome of the study: mean arterial blood pressure, heart rate, respiratory rate, adverse effects, block related complication, sedation score (by Ramsay sedation scale) and pain score (by Visual Analog Scale)

Timeline

Start
2024-01-01
Primary completion
2025-01-01
Completion
2025-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 2 mg Other
Comparator Bupivacaine Other / unclassified 20 mg Other

Indications